Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Global Lichen Sclerosus Treatment Market - 2022-2029
... at a CAGR of XX% during the forecast period (2022-2029). Lichen sclerosus is a skin condition that affects the vaginal and anal regions. They may, however, form on the upper body, such as the arms ... Read More
-
Major Depressive Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... there will be more than 18 million diagnosed prevalent cases of MDD across 16 pharmaceutical markets. There are four leading marketed drugs for the treatment of MDD, Otsuka Pharmaceutical is a key player in the ... Read More
-
Rosacea Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... than 47 million diagnosed prevalent cases of rosacea across 16 pharmaceutical markets. There are 10 FDA approved branded marketed drugs for the treatment of rosacea. The rosacea pipeline consists of over 32 pharmaceuticals spanning all ... Read More
-
Global Meniere’s Disease Treatment Market - 2022-2029
... a CAGR of XX % during the forecast period (2022-2029). Ménière’s disease is a chronic disorder of the inner ear that affects both balance and hearing. It usually affects just one ear and can cause ... Read More
-
Global Peptide Therapeutics Market - 2022-2029
... bind to specific cell surface receptors, such as ion channels and G protein-coupled receptors (GPCRs), and trigger intracellular effects. They are employed in the pharmaceutical industry to design novel regenerative therapeutics that can target a ... Read More
-
Global Splenomegaly Therapeutics Market - 2022-2029
... CAGR of XX % during the forecast period (2022-2029). Splenomegaly is a condition in which the spleen grows in size or weight. Hematopoiesis and immunosurveillance are important functions of the spleen. The spleen's main functions ... Read More
-
Aicardi-Goutieres Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... than 4,000 prevalent cases of AGS each in 2022 across the 16 countries covered in GlobalData’s epidemiology forecast. No FDA-approved marketed drugs are available for AGS, only symptomatic treatment is indicated for disease management. The ... Read More
-
2022 Global Forecast for Anti Asthma Drugs Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales ... Read More
-
2022 Global Forecast for Anti-Suicide Drugs Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
2022 Global Forecast for Angioimmunoblastic T-Cell Lymphoma (Ailt) Treatment Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... over 50 countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or ... Read More
-
2022 Global Forecast for Anti Obesity Drugs Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales ... Read More
-
Global Next-Generation Antibody Therapeutics Market: Market Segments: By Therapeutic Area (Oncology Autoimmune/Inflammatory); By Technology (Antibody-Drug Conjugates (ADCs), Bispecific Antibodies, Fc-engineered Antibodies, Antibody Fragments and Antibody-like Proteins & Biosimilar Antibody Products);and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030
... Size, Share & Trends for 2014 – 2019 and Forecasts to 2030 Product Overview Use of a new improvised therapeutic antibody to form novel medicines for the treatment of different diseases includes next-generation antibody therapeutics. ... Read More
-
2022 Global Forecast for Anti-Glaucoma Drug Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
2022 Global Forecast for Anxiolytics Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
2022 Global Forecast for Antidepressants (2023-2028 Outlook)-High Tech & Emerging Markets Report
... market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments value) ... Read More
-
2022 Global Forecast for Anti-Migraine Drugs Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
2022 Global Forecast for Anemia Drugs Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Computational Biology Market By Application (Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software), By Services (In-house, Contract), By End Use (Academics & Research, Commercial): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Opportunity Analysis and Industry Forecast, 2021-2031 The global computational biology market was valued at $5,493.2 million in 2021, and is projected to reach $31,477.1 million by 2031, registering a CAGR of 19.5% from 2022 to ... Read More
-
Marburgvirus Infections (Marburg Hemorrhagic Fever) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Fever) - Drugs In Development, 2022, provides an overview of the Marburgvirus Infections (Marburg Hemorrhagic Fever) (Infectious Disease) pipeline landscape. Marburg hemorrhagic fever is a rare, acute infectious which affects both human and nonhuman primates. ... Read More
-
Achondroplasia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Achondroplasia (Musculoskeletal Disorders) pipeline landscape. Achondroplasia is a bone growth disorder that causes disproportionate dwarfism. This is caused by mutations in the FGFR3 gene. Symptoms include decreased muscle tone, apnea, hydrocephalus, short ... Read More
-
Influenzavirus B Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Influenzavirus B Infections (Infectious Disease) pipeline landscape. Type B influenza is a subtype of the influenza virus that tends to occur sporadically. Symptoms include runny nose, sore throat, ... Read More
-
Anesthetic Effect Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Anesthetic Effect (Central Nervous System) pipeline landscape. Anesthetic effect causes a loss of consciousness. The factors that can increase risk of complications include smoking, obstructive sleep apnea, obesity, high blood ... Read More
-
Mild Cognitive Impairment Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Mild Cognitive Impairment (Central Nervous System) pipeline landscape. Mild cognitive impairment (MCI) is a condition involving problems with cognitive function (such as thinking, knowing and remembering). MCI is ... Read More
-
Gamma-Aminobutyric Acid Receptor Subunit Alpha 3 (GABA(A) Receptor Subunit Alpha 3 or GABRA3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... recently published report 'Gamma-Aminobutyric Acid Receptor Subunit Alpha 3 - Drugs In Development, 2022'; Gamma-Aminobutyric Acid Receptor Subunit Alpha 3 (GABA(A) Receptor Subunit Alpha 3 or GABRA3) pipeline Target constitutes close to 6 molecules. Out ... Read More
-
Polycystic Ovarian Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Polycystic Ovarian Syndrome (Women's Health) pipeline landscape. Polycystic ovary syndrome (PCOS) is a common hormonal disorder among women of reproductive age. Symptoms include menstrual abnormality, acne, thinning hair ... Read More
Research Assistance
